Cargando…
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) use has been linked to persistent alterations of the brain serotonergic (5-HT) system in animal and human studies, but the molecular underpinnings are still unclear. Cytoskeletal structures such as neurofilament light chain (NfL) are promising mark...
Autores principales: | Bavato, F., Stamatakos, S., Ohki, C. M. Yde, Seifritz, E., Romualdi, P., Grünblatt, E., Quednow, B. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188522/ https://www.ncbi.nlm.nih.gov/pubmed/35420371 http://dx.doi.org/10.1007/s00702-022-02502-8 |
Ejemplares similares
-
Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017) -
Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study
por: Yde Ohki, Cristine Marie, et al.
Publicado: (2023) -
A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022) -
Beyond ecstasy: Alternative entactogens to
3,4-methylenedioxymethamphetamine with potential applications in
psychotherapy
por: Oeri, Hans Emanuel
Publicado: (2020) -
Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)